PRINCETON, NJ –– Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it has appointed Gavin Nichols to the newly-created position of president of technology. Mr. Nichols will also serve as the head of Certara’s Software Business Unit and be based in its Cary, North Carolina office. In his […]
Palo Alto, California — PREMIER Biosoft today announced that eminent protein biochemist, John Wiktorowicz, PhD, has joined the company’s scientific advisory board. “We are very pleased to welcome Dr. Wiktorowicz to our scientific advisory board and look forward to his guidance as we deploy informatics to serving proteomics research,” said Arun Apte, Chief Executive Officer […]
ALAMEDA, Calif. -– LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect, a powerful, yet easy-to-use application for prioritizing gene variants resulting from next generation sequencing (“NGS”) experiments. VarElect rapidly prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in […]
CAMBRIDGE, UK -– Optibrium™ and NextMove Software, developers of software and chemoinformatics solutions for drug discovery, today announced an agreement to collaborate on the integration of NextMove Software’s Matsy technology with Optibrium’s StarDrop software suite. The combination of these technologies will help guide scientists to quickly identify novel compounds based on matched molecular series analysis […]
Harderwijk, the Netherlands and Waltham, Mass –– Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients’ genomes. GENALICE MAP is an ultra-fast and highly accurate preprocessing solution for aligning and calling NGS data and […]
SAN FRANCISCO — Protea Biosciences Group, Inc. (PRGB) (“Protea”) announced today that it has developed a new software platform, known as “Histology Guided Mass Spec Imaging (HG-MSI)”, that enables pathologists to combine traditional microscopy and histology with high resolution mass spectrometry molecular imaging. The Company made the announcement today while presenting at the Biotech Showcase(TM) […]
PLEASANTON, Calif. — 10X Genomics, a provider of an innovative genomics platform, today announced that it has raised $55.5 Million in its Series B financing. Foresite Capital Management led the B round and was joined by the Series A lead, Venrock, as well as new and existing investors, including Paladin Capital Group and funds managed […]
SHANGHAI — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announces that it has acquired NextCODE Health, a leading genomic analysis and bioinformatics company with operations in the United States and Iceland, […]
SHANGHAI — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announces that it has acquired NextCODE Health, a leading genomic analysis and bioinformatics company with operations in the United States and Iceland, […]
MADISON, Wisconsin –– DNASTAR® announced today that it has been appointed by the University of Michigan as the exclusive provider of the award-winning I-TASSER structure prediction software to commercial entities worldwide. DNASTAR, which has had broad rights to distribute the I-TASSER software since 2012, will now be the sole authorized commercial distributor. The I-TASSER algorithms […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
